Modulation of intrinsic inhibitory checkpoints using nano‐carriers to unleash NK cell activity
出版年份 2021 全文链接
标题
Modulation of intrinsic inhibitory checkpoints using nano‐carriers to unleash NK cell activity
作者
关键词
-
出版物
EMBO Molecular Medicine
Volume 14, Issue 1, Pages -
出版商
EMBO
发表日期
2021-11-02
DOI
10.15252/emmm.202114073
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
- (2020) Aviad Ben-Shmuel et al. Frontiers in Immunology
- The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
- (2019) Fernando Souza-Fonseca-Guimaraes et al. TRENDS IN IMMUNOLOGY
- Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System
- (2019) Shweta Joshi et al. Journal of Oncology
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- (2019) Filipe Martins et al. Nature Reviews Clinical Oncology
- NK cells to cure cancer
- (2019) Clara Di Vito et al. SEMINARS IN IMMUNOLOGY
- The Cellular Immunotherapy Revolution: Arming the Immune System for Precision Therapy
- (2019) Richard D. Paucek et al. TRENDS IN IMMUNOLOGY
- Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
- (2019) Laurent Gauthier et al. CELL
- Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
- (2019) Weilei Hu et al. Frontiers in Immunology
- Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
- (2019) Jayesh A. Kulkarni et al. ACCOUNTS OF CHEMICAL RESEARCH
- Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators
- (2019) João Conniot et al. Nature Nanotechnology
- The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
- (2019) Haoyu Sun et al. Frontiers in Immunology
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Strategies to enhance NK cell function for the treatment of tumors and infections
- (2018) Jacquelyn Freund-Brown et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Actin retrograde flow controls natural killer cell response by regulating the conformation state of SHP‐1
- (2018) Omri Matalon et al. EMBO JOURNAL
- Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells
- (2018) Suresh Bugide et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Natural killer cells in inflammation and autoimmunity
- (2018) Beatrice Zitti et al. CYTOKINE & GROWTH FACTOR REVIEWS
- FDA approves patisiran to treat hereditary transthyretin amyloidosis
- (2018) Heather Wood Nature Reviews Neurology
- TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
- (2017) William C. Dougall et al. IMMUNOLOGICAL REVIEWS
- Natural Killer Cells: Angels and Devils for Immunotherapy
- (2017) Beatriz Martín-Antonio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy
- (2017) Robert Torphy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation
- (2017) Josefa A. Rodríguez Oncology Letters
- Clinical Applications of Immunotherapy Combination Methods and New Opportunities for the Future
- (2017) Ece Esin Biomed Research International
- Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset
- (2017) Mathieu Amand et al. Frontiers in Immunology
- Expression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher Activity
- (2017) Yonat Shemer-Avni et al. Frontiers in Immunology
- Combination immunotherapy: a road map
- (2017) Patrick A. Ott et al. Journal for ImmunoTherapy of Cancer
- Targeting protein function: the expanding toolkit for conditional disruption
- (2016) A. E. Campbell et al. BIOCHEMICAL JOURNAL
- Immune targets and neoantigens for cancer immunotherapy and precision medicine
- (2016) Rong-Fu Wang et al. CELL RESEARCH
- Targeting NKG2D and NKp30 Ligands Shedding to Improve NK Cell-Based Immunotherapy
- (2016) Alessandra Zingoni et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Targeting natural killer cells in cancer immunotherapy
- (2016) Camille Guillerey et al. NATURE IMMUNOLOGY
- Suppressing the killer instinct
- (2016) Kerry S. Campbell Science Signaling
- Dephosphorylation of the adaptor LAT and phospholipase C–γ by SHP-1 inhibits natural killer cell cytotoxicity
- (2016) Omri Matalon et al. Science Signaling
- Suppressing the killer instinct
- (2016) Kerry S. Campbell Science Signaling
- Dephosphorylation of the adaptor LAT and phospholipase C–γ by SHP-1 inhibits natural killer cell cytotoxicity
- (2016) Omri Matalon et al. Science Signaling
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Practical NK cell phenotyping and variability in healthy adults
- (2015) Laura S. Angelo et al. IMMUNOLOGIC RESEARCH
- Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
- (2015) Carin I. M. Dahlberg et al. Frontiers in Immunology
- Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes
- (2015) Rami Yossef et al. PLoS One
- Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease
- (2014) James O.J. Davies et al. CYTOTHERAPY
- The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
- (2014) Magdalena Paolino et al. NATURE
- Application of liposomes in medicine and drug delivery
- (2014) Hadis Daraee et al. Artificial Cells Nanomedicine and Biotechnology
- Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells
- (2014) Guido Ferlazzo et al. Frontiers in Immunology
- A review of the current status of siRNA nanomedicines in the treatment of cancer
- (2013) Pauline Resnier et al. BIOMATERIALS
- A daunting task: manipulating leukocyte function with RNAi
- (2013) Dan Peer IMMUNOLOGICAL REVIEWS
- RNAi-based nanomedicines for targeted personalized therapy
- (2012) Ala Daka et al. ADVANCED DRUG DELIVERY REVIEWS
- NK cell MHC class I specific receptors (KIR): from biology to clinical intervention
- (2012) Ariane Thielens et al. CURRENT OPINION IN IMMUNOLOGY
- Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1
- (2012) A. Glasner et al. JOURNAL OF IMMUNOLOGY
- Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers
- (2011) Gideon Bachar et al. BIOMATERIALS
- The Suppressive Tumor Microenvironment: A Challenge in Cancer Immunotherapy
- (2011) Elizabeth A. Vasievich et al. MOLECULAR PHARMACEUTICS
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- SHP-2 Expression Negatively Regulates NK Cell Function
- (2009) A. K. Purdy et al. JOURNAL OF IMMUNOLOGY
- Natural killer cell-based immunotherapy in cancer: current insights and future prospects
- (2009) T. Sutlu et al. JOURNAL OF INTERNAL MEDICINE
- Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
- (2009) Aimee L. Jackson et al. NATURE REVIEWS DRUG DISCOVERY
- Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)
- (2008) J DEVINCENZO et al. ANTIVIRAL RESEARCH
- Inhibitory Receptor Signaling via Tyrosine Phosphorylation of the Adaptor Crk
- (2008) Mary E. Peterson et al. IMMUNITY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
- (2008) D. Peer et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now